A 2025 retrospective cohort study of 210 T2DM patients on oral semaglutide for 18 months found no significant association between rs6923761 or rs761387 genotypes and changes in HbA1c or BMI in that relatively well-controlled population (Candido et al., 2025) suggesting that receptor-level genotype effects may be detectable primarily in subpopulations with higher pharmacological demand or larger baseline disease severity, rather than as universal predictors
In all future years, diabetes incidence is predicted by FAMs diabetes risk equation that accounts for BMI and other health and socioeconomic characteristics
Find out why this is one of Phoenixs Points of Pride
Second Natures Wegovy programme combines the medication with support from registered dietitians and a structured habit-change programme, built around the balanced plate model and sustainable changes rather than restrictive dieting
Custom Dosing and Regular Monitoring A standout benefit of personalized programs like TrimRX is the ability to fine-tune medication dosing based on your bodys individual response
This metabolic improvement supports sustained energy levels and reduces the likelihood of regaining weight once you stop the medication